Advanced metastatic midgut neuroendocrine tumors: New drug in development shows improved progression-free survival for patients

A new therapy in development for the treatment of midgut neuroendocrine tumors, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease.